Related Experiment Videos
T and B lymphocytes in myasthenia gravis
Clinical and Experimental Immunology
|September 1, 1979
Summary
Myasthenia gravis (MG) patients show increased erythrocyte-haemolysin-complement rosette-forming cells (EA(H)C-RFC), indicating potential immune system alterations. This finding was observed in both thymectomized and non-thymectomized individuals with MG.
Area of Science:
- Immunology
- Cellular Biology
- Neurology
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- Understanding lymphocyte subsets in MG is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To investigate the presence and characteristics of T and B lymphocytes in patients with myasthenia gravis.
- To compare lymphocyte populations in thymectomized and non-thymectomized MG patients with healthy controls.
Main Methods:
- Peripheral blood lymphocytes were analyzed using sheep red blood cell (SRBC) rosette formation.
- T cells were identified by spontaneous SRBC rosette formation.
- B cells were quantified using erythrocyte antibody complement (EAC) rosette assays, distinguishing between EA(H)C-RFC and EA(M)C-RFC.
Main Results:
- No significant alterations in the percentage of total lymphocytes or T cells were found in MG patients.
- The percentage of 'active' T cells remained similar between MG patients and controls.
- A significant increase in EA(H)C-RFC was observed in both thymectomized and non-thymectomized MG patients.
- No alterations were detected in B cells identified by EA(M)C-RFC.
Conclusions:
- The increase in EA(H)C-RFC in MG patients suggests a potential role for 19S antibody-forming B lymphocytes or T cells with Fc receptors.
- These findings may contribute to a better understanding of the immunological basis of myasthenia gravis.